Effects of Cranberry Extractive on the Lipid Profiles in Subjects With Type 2 Diabetes (NCT00695526) | Clinical Trial Compass
CompletedPhase 3
Effects of Cranberry Extractive on the Lipid Profiles in Subjects With Type 2 Diabetes
Taiwan30 participantsStarted 2006-05
Plain-language summary
Cranberry, containing flavonoids, is effective on improvement of lipid profiles in non-diabetic subjects. The Hypothesis of is to assess the effect of cranberry on lipid profiles in type 2 diabetic patients using oral antidiabetic drugs.
Who can participate
Age range50 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* type 2 diabetic subjects
* age between 50 and 75 years
Exclusion Criteria:
* glycosylated hemoglobin (HbA1c) less than 7% or more than 10%;
* triglyceride more than 4.5 mmol/L;
* current insulin treatment;
* change of the medications for anti-diabetes, hypertension, hyperlipidemia and anti-platelet in recent four weeks;
* abnormal renal function (serum creatinine \> 177 ÎĽmol/L;
* abnormal liver function test results (more than two-fold upper limit of normal range);
* severe systemic disease such as immune disorder, cancer, acute or chronic inflammation disease;
* smoking in recent 1 year;
* alcoholism (more than two drinks daily);
* using steroid or drugs with unknown components;
* pregnancy or breast-feeding.